Resmetirom for nonalcoholic steatohepatitis
J Manag Care Spec Pharm
.
2023 Oct;29(10):1169-1172.
doi: 10.18553/jmcp.2023.29.10.1169.
Authors
Shahariar Mohammed Fahim
1
,
Jeffrey A Tice
2
,
Kangho Suh
3
,
Josh J Carlson
4
,
Marina Richardson
1
,
Janet N Chu
2
,
Belen Herce-Hagiwara
1
,
Foluso Agboola
1
,
David Rind
1
,
Steven D Pearson
1
Affiliations
1
Institute for Clinical and Economic Review, Boston, MA.
2
Division of General Internal Medicine, University of California San Francisco.
3
School of Pharmacy, University of Pittsburgh, Pittsburgh, PA.
4
Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute, School of Pharmacy, University of Washington, Seattle.
PMID:
37776115
PMCID:
PMC10541630
DOI:
10.18553/jmcp.2023.29.10.1169
No abstract available